Chemoinformaics analysis of 2,6-Dimethylbicyclo[3.2.1]octane
Molecular Weight | 138.254 | nRot | 0 |
Heavy Atom Molecular Weight | 120.11 | nRig | 9 |
Exact Molecular Weight | 138.141 | nRing | 2 |
Solubility: LogS | -4.537 | nHRing | 0 |
Solubility: LogP | 3.855 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 28.7023 |
nHD | 0 | BPOL | 18.0577 |
QED | 0.482 |
Synth | 4.509 |
Natural Product Likeliness | 1.601 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.546 |
MDCK | 0.0000191 |
BBB | 0.886 |
PPB | 0.941811 |
VDSS | 2.302 |
FU | 0.0511594 |
CYP1A2-inh | 0.726 |
CYP1A2-sub | 0.852 |
CYP2c19-inh | 0.136 |
CYP2c19-sub | 0.919 |
CYP2c9-inh | 0.453 |
CYP2c9-sub | 0.829 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.799 |
CYP3a4-inh | 0.341 |
CYP3a4-sub | 0.435 |
CL | 16.017 |
T12 | 0.191 |
hERG | 0.038 |
Ames | 0.047 |
ROA | 0.023 |
SkinSen | 0.826 |
Carcinogencity | 0.11 |
EI | 0.983 |
Respiratory | 0.223 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.926983 |